October 21, 2016 8:55 PM ET


Company Overview of Gennova Biopharmaceuticals Ltd.

Company Overview

Gennova Biopharmaceuticals Ltd., a biotechnology company, develops and delivers advance specialty biopharmaceuticals products. The company manufactures and markets its own brands of TNK-tPA (Tissue-Plasminogen Activator), GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor), and EPO (recombinant human erythropoietin). The company was incorporated in 2001 and is based in Pune, India. Gennova Biopharmaceuticals Ltd. operates as a subsidiary of Emcure Pharmaceuticals Limited.

Emcure House

T 184



Pune,  411 026


Founded in 2001


91 20 3061 0000


91 20 3061 0200

Key Executives for Gennova Biopharmaceuticals Ltd.

Chief Executive Officer
Age: 47
Compensation as of Fiscal Year 2016.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Gennova Biopharmaceuticals Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.